{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:13:43Z","timestamp":1771326823972,"version":"3.50.1"},"reference-count":212,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1053\/j.seminoncol.2010.10.014","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T10:04:37Z","timestamp":1292493877000},"page":"594-618","source":"Crossref","is-referenced-by-count":149,"title":["Pancreatic Endocrine Tumors"],"prefix":"10.1053","volume":"37","author":[{"given":"Kjell","family":"\u00d6berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2010.10.014_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000098012","article-title":"Well-differentiated pancreatic nonfunctioning tumors\/carcinoma","volume":"84","author":"Falconi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib2","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1245\/s10434-007-9566-6","article-title":"Population-based study of islet cell carcinoma","volume":"14","author":"Yao","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF01297144","article-title":"Clinical pathology of endocrine tumors of the pancreas","volume":"36","author":"Kimura","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1590-8658(01)80710-6","article-title":"Digestive neuroendocrine tumours: diagnosis and treatment in Italy","volume":"33","author":"Corleto","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib6","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/j.1572-0241.2003.07704.x","article-title":"Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study","volume":"98","author":"Gullo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2005.05.008","article-title":"Insulinoma","volume":"19","author":"Grant","year":"2005","journal-title":"Best Pract Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000098010","article-title":"Well-differentiated pancreatic tumor\/carcinoma: insulinoma","volume":"84","author":"de Herder","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2007.01.004","article-title":"Tumour biology and histopathology of neuroendocrine tumours","volume":"21","author":"Kloppel","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12022-007-0025-5","article-title":"Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors","volume":"18","author":"Kloppel","year":"2007","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/IJGC:25:2:77","article-title":"The link between exocrine pancreatic cancer and the endocrine pancreas","volume":"25","author":"Pour","year":"1999","journal-title":"Int J Pancreatol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.1927.02690050014007","article-title":"Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia","author":"Wilder","year":"1927","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00000658-195510000-00015","article-title":"Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas","volume":"142","author":"Zollinger","year":"1955","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(58)90075-5","article-title":"Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia","volume":"25","author":"Verner","year":"1958","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)91343-9","article-title":"A glucagonoma syndrome","author":"Mallison","year":"1974","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(77)92113-4","article-title":"Pancreatic somatostatinoma","volume":"1","author":"Larsson","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI110708","article-title":"Somatotroph hyperplasia","volume":"70","author":"Thorner","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4158\/EP.12.6.656","article-title":"Cushing's syndrome attributable to ectopic secretion of corticotropin in a patient with two neuroendocrine tumors","volume":"12","author":"Salvatori","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.meg.0000223908.00987.18","article-title":"Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia","volume":"19","author":"Mussig","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000080901","article-title":"Calcitonin-secreting tumor of the pancreas","volume":"21","author":"Mullerpatan","year":"2004","journal-title":"Dig Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(03)12256-8","article-title":"A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes","volume":"361","author":"Todd","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1210\/jc.87.3.1300","article-title":"Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors","volume":"87","author":"Volante","year":"2002","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib23","series-title":"Endocrine pathology","first-page":"205","article-title":"Endocrine pancreas","author":"Lubensky","year":"2002"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib25","series-title":"World Health Organization histological classification of tumours","first-page":"38","article-title":"Histological typing of endocrine tumours","author":"Solcia","year":"2000"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2003-031575","article-title":"Non-islet origin of pancreatic islet cell tumors","volume":"89","author":"Vortmeyer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0016-5085(90)90459-E","article-title":"Multiple hormone elevations in Zollinger-Ellison syndrome","volume":"99","author":"Chiang","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bpg.2005.03.005","article-title":"Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics","volume":"19","author":"Rindi","year":"2005","journal-title":"Best Pract Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib29","series-title":"World Health Organization classification of tumors pathology and genetics of tumors of endocrine organs","first-page":"177","article-title":"Pancreatic endocrine tumours","author":"Heitz","year":"2004"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib30","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1210\/jc.82.8.2622","article-title":"Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones","volume":"82","author":"Nobels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.regpep.2004.08.027","article-title":"A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B","volume":"125","author":"Stridsberg","year":"2005","journal-title":"Regul Peptides"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2010.10.014_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051853","article-title":"Tumor markers in neuroendocrine tumors","volume":"62","author":"Eriksson","year":"2000","journal-title":"Digestion"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib33","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1158\/1078-0432.CCR-08-0734","article-title":"Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution","volume":"14","author":"Ekeblad","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib35","series-title":"UICC: TNM classification of malignant tumours","author":"Sobin","year":"2009"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/modpathol.2010.58","article-title":"Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients","volume":"23","author":"Scarpa","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2006.12.001","article-title":"Molecular genetics of neuroendocrine tumors","volume":"21","author":"Duerr","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib38","first-page":"313","article-title":"Molecular alterations during insulinoma tumorigenesis","volume":"1775","author":"Jonkers","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib40","first-page":"2238","article-title":"Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors","volume":"57","author":"Debelenko","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<258::AID-GCC11>3.0.CO;2-2","article-title":"Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors","volume":"26","author":"Hessman","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1677\/erc.1.01153","article-title":"Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets","volume":"13","author":"Capurso","year":"2006","journal-title":"Endocr Rel Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/ERC-07-0194","article-title":"Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis","volume":"15","author":"Duerr","year":"2008","journal-title":"Endocr Rel Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib44","first-page":"597","article-title":"Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases","volume":"75","author":"Stefanini","year":"1974","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0889-8529(18)30388-8","article-title":"Insulin-producing islet cell tumors","volume":"18","author":"Fajans","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncr.21179","article-title":"Malignant insulinoma: spectrum of unusual clinical features","volume":"104","author":"Hirshberg","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib47","series-title":"Endocrine surgery update","first-page":"246","article-title":"The diagnosis and treatment of insulinomas","author":"Kaplan","year":"1983"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2362.2003.01158.x","article-title":"Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism","volume":"33","author":"Kaczirek","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib49","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00125-005-1933-x","article-title":"Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia","volume":"48","author":"Patti","year":"2005","journal-title":"Diabetologia"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-07-0109","article-title":"Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism","volume":"157","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa043690","article-title":"Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery","volume":"353","author":"Service","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib52","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/00000658-193506000-00001","article-title":"Adenomas of the islet cells with hyperinsulinism","volume":"101","author":"Whipple","year":"1935","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0889-8529(05)70085-2","article-title":"Classification of hypoglycemic disorders","volume":"28","author":"Service","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib54","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.73.864.640","article-title":"Diazoxide treatment for insulinoma: a national UK survey","volume":"73","author":"Gill","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJMc0806740","article-title":"Glycemic control in patients with insulinoma treated with everolimus","volume":"360","author":"Kulke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib56","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib57","first-page":"145","article-title":"Neuroendocrine tumors","volume":"21","author":"Plockinger","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF03040916","article-title":"The importance of preoperative localisation procedures in organic hyperinsulinism\u2014experience in 67 patients","volume":"116","author":"Kaczirek","year":"2004","journal-title":"Wiener Klin Wochenschr"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.suc.2004.02.004","article-title":"Surgical treatment of insulinomas","volume":"84","author":"Finlayson","year":"2004","journal-title":"Surgical Clin North Am"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gassur.2004.06.009","article-title":"Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1","volume":"9","author":"Fernandez-Cruz","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib61","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0026-0495(03)00200-2","article-title":"Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells","volume":"52","author":"Won","year":"2003","journal-title":"Metabolism"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib62","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib63","series-title":"Surgical endocrinology: clinical syndromes","first-page":"291","article-title":"Zollinger-Ellison syndrome","author":"Jensen","year":"2001"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib64","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2174\/156802607780960483","article-title":"The biology of cholecystokinin and gastrin peptides","volume":"7","author":"Rehfeld","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9610(84)90029-1","article-title":"The gastrinoma triangle: operative implications","volume":"147","author":"Stabile","year":"1984","journal-title":"Am J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11894-005-0049-2","article-title":"Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome","volume":"7","author":"Gibril","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bpg.2005.05.009","article-title":"Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment","volume":"19","author":"Hoffmann","year":"2005","journal-title":"Best Pract Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1067\/msy.1998.93110","article-title":"Surgical treatment of localized gastrinoma within the liver: a prospective study","volume":"124","author":"Norton","year":"1998","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib69","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.SLA.0000064375.51939.48","article-title":"Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study","volume":"237","author":"Norton","year":"2003","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/gast.1997.v112.pm9024311","article-title":"Primary cardiac gastrinoma causing Zollinger-Ellison syndrome","volume":"112","author":"Gibril","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1053\/gast.2001.23242","article-title":"A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer","volume":"120","author":"Abou-Saif","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00000658-196409000-00013","article-title":"The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases","volume":"160","author":"Ellison","year":"1964","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib73","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.1997.15.6.2420","article-title":"Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns","volume":"15","author":"Sutliff","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib74","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1053\/j.seminoncol.2010.10.014_bib75","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib77","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00005792-200011000-00004","article-title":"Zollinger-Ellison syndrome","volume":"79","author":"Roy","year":"2000","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib78","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1365-2036.2001.01085.x","article-title":"Does the widespread use of proton pump inhibitors mask, complicate and\/or delay the diagnosis of Zollinger-Ellison syndrome?","volume":"15","author":"Corleto","year":"2001","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-98-1-59","article-title":"Zollinger-Ellison syndrome: current concepts and management","volume":"98","author":"Jensen","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-200105000-00005","article-title":"Gastric secretion in Zollinger-Ellison syndrome","volume":"80","author":"Roy","year":"2001","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib81","first-page":"958","article-title":"Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study","volume":"102","author":"Norton","year":"1987","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0b013e31802b518c","article-title":"Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib84","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-111-9-713","article-title":"Secretin and calcium provocative tests in the Zollinger-Ellison syndrome","volume":"111","author":"Frucht","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib85","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2007-0986","article-title":"Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results","volume":"92","author":"Long","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib86","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1210\/jc.85.11.4131","article-title":"Expression of the calcium-sensing receptor in gastrinomas","volume":"85","author":"Goebel","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2036.1993.tb00140.x","article-title":"Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety","volume":"7","author":"Metz","year":"1993","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib88","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/j.1572-0241.2007.01509.x","article-title":"Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion","volume":"102","author":"Metz","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib89","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1046\/j.1365-2036.2001.01097.x","article-title":"Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study","volume":"15","author":"Hirschowitz","year":"2001","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib90","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(98)00087-4","article-title":"Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome","volume":"104","author":"Termanini","year":"1998","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib91","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib92","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/gut.2005.090514","article-title":"Proton pump inhibitors and gastric neoplasia","volume":"55","author":"Kuipers","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib93","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2007.06.022","article-title":"Chronic proton pump inhibitor therapy and the risk of colorectal cancer","volume":"133","author":"Yang","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib94","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00000658-198009000-00018","article-title":"Primary peptic ulcerations of the jejunum associated with islet cell tumors","volume":"192","author":"Zollinger","year":"1980","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib95","first-page":"1104","article-title":"Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: results of a 16-year prospective study","volume":"91","author":"McArthur","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib96","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zollinger-Ellison syndrome","volume":"341","author":"Norton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0960-7404(03)00035-5","article-title":"Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1)","volume":"12","author":"Norton","year":"2003","journal-title":"Surg Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib98","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib99","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00423-001-0274-6","article-title":"Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1","volume":"386","author":"Akerstrom","year":"2002","journal-title":"Langenbecks Arch Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib100","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jc.86.11.5282","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib101","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor?","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s005340050052","article-title":"Glucagonomas\/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases","volume":"5","author":"Soga","year":"1998","journal-title":"J Hepatobiliary Pancreatic Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12032-007-0011-2","article-title":"Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years","volume":"24","author":"Kindmark","year":"2007","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib106","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"van Beek","year":"2004","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198003000-00002","article-title":"Clinical and metabolic aspects of glucagonoma","volume":"59","author":"Leichter","year":"1980","journal-title":"Medicine"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib108","series-title":"Endocrine tumors of the pancreas: recent advances in research and management","first-page":"183","article-title":"Glucagonomas: clinical presentation, diagnosis, and advances in management","author":"Guillausseau","year":"1995"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4158\/EP.9.1.22","article-title":"Reproduction of features of the glucagonoma syndrome with continuous intravenous glucagon infusion as therapy for tumor-induced hypoglycemia","volume":"9","author":"Case","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib110","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00431-002-1022-9","article-title":"Glucagon therapy as a possible cause of erythema necrolyticum migrans in two neonates with persistent hyperinsulinaemic hypoglycaemia","volume":"161","author":"Wald","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib111","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.0303-6987.2006.00408.x","article-title":"Necrolytic migratory erythema","volume":"33","author":"Kovacs","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib112","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2036.2000.00738.x","article-title":"Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR","volume":"14","author":"Tomassetti","year":"2000","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib113","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-4632.2004.01844.x","article-title":"Necrolytic migratory erythema: clinicopathologic study of 13 cases","volume":"43","author":"Pujol","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib114","first-page":"4","article-title":"Etiology and pathogenesis of necrolytic migratory erythema: review of the literature","volume":"6","author":"Tierney","year":"2004","journal-title":"Med Gen Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib115","series-title":"Endocrine tumors of the pancreas: Recent advances in research and management","first-page":"166","article-title":"VIPomas and endocrine cholera: clinical presentation, diagnosis, and advances in management","author":"Matuchansky","year":"1995"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib116","first-page":"1259","article-title":"VIPomas: an update in diagnosis and management in a series of 11 patients","volume":"52","author":"Nikou","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib117","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1067\/msy.1998.92005","article-title":"Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature","volume":"124","author":"Smith","year":"1998","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib118","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM198312153092403","article-title":"Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide","volume":"309","author":"Kane","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib119","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/1097-0142(19831115)52:10<1860::AID-CNCR2820521017>3.0.CO;2-F","article-title":"Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors","volume":"52","author":"Capella","year":"1983","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11605-007-0177-0","article-title":"Pancreatic VIPomas: subject review and one institutional experience","volume":"12","author":"Ghaferi","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01296914","article-title":"A report of five patients with large-volume secretory diarrhea but no evidence of endocrine tumor or laxative abuse","volume":"27","author":"Read","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib122","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1373\/clinchem.2006.077883","article-title":"Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography","volume":"53","author":"Shelton","year":"2007","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM198501033120104","article-title":"Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera","volume":"312","author":"Maton","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib124","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(85)91265-6","article-title":"Successful treatment of therapy-resistant pancreatic cholera with human leucocyte interferon","volume":"1","author":"Oberg","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib125","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1136\/bmj.282.6278.1767","article-title":"Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas)","volume":"282","author":"Long","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000090257","article-title":"Radiofrequency ablation has a valuable therapeutic role in metastatic VIPoma","volume":"6","author":"Moug","year":"2006","journal-title":"Pancreatology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib127","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM197704282961703","article-title":"\u201dSomatostatinoma\u201d: a somatostatin-containing tumor of the endocrine pancreas","volume":"296","author":"Ganda","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM197908093010601","article-title":"Somatostatinoma syndrome","volume":"301","author":"Krejs","year":"1979","journal-title":"N Engl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/ERC-07-0157","article-title":"Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity","volume":"15","author":"Garbrecht","year":"2008","journal-title":"Endocr Rel Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib130","first-page":"13","article-title":"Somatostatinoma\/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas","volume":"18","author":"Soga","year":"1999","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1440-1827.2000.01016.x","article-title":"Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis","volume":"50","author":"Tanaka","year":"2000","journal-title":"Pathol Int"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib132","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4158\/EP.12.4.394","article-title":"Spectrum of malignant somatostatin-producing neuroendocrine tumors","volume":"12","author":"Moayedoddin","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib133","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00534-004-0918-3","article-title":"Duodenal somatostatinoma associated with Von Recklinghausen's disease","volume":"11","author":"Fendrich","year":"2004","journal-title":"J Hepatobiliary Pancreatic Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.2311048.x","article-title":"Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome","volume":"47","author":"Losa","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11102-006-0267-0","article-title":"Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects","volume":"9","author":"Gola","year":"2006","journal-title":"Pituitary"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib136","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11102-007-0045-7","article-title":"Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients","volume":"10","author":"Biermasz","year":"2007","journal-title":"Pituitary"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib137","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-032164","article-title":"Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence","volume":"89","author":"Miehle","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushing's syndrome in patients with the Zollinger-Ellison syndrome","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib139","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome","volume":"17","author":"Yu","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000151222","article-title":"Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review","volume":"89","author":"Srirajaskanthan","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib141","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/cncr.21291","article-title":"Carcinoids of the pancreas: an analysis of 156 cases","volume":"104","author":"Soga","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib142","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.2006.02695.x","article-title":"Co-expression of ghrelin and its receptor in pancreatic endocrine tumours","volume":"66","author":"Ekeblad","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2010.10.014_bib143","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000080739","article-title":"Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours","volume":"80","author":"Plockinger","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib144","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0196-9781(01)00606-4","article-title":"Pancreatic polypeptide-related tumors","volume":"23","author":"Bordi","year":"2002","journal-title":"Peptides"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib145","doi-asserted-by":"crossref","DOI":"10.1159\/000318771","article-title":"Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior","author":"Boninsegna","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib146","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1994.tb17291.x","article-title":"Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors","volume":"733","author":"Krenning","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib147","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000658-199608000-00002","article-title":"The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors","volume":"224","author":"van Eijck","year":"1996","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib148","first-page":"469","article-title":"Surgical treatment of nonfunctioning islet cell tumor: report of 41 cases","volume":"3","author":"Guo","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib149","series-title":"Surgical endocrinology","first-page":"361","article-title":"Nonfunctional pancreatic islet cell tumors","author":"Hochwald","year":"2001"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0889-8529(05)70150-X","article-title":"Multiple endocrine neoplasia type 1","volume":"29","author":"Thakker","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib151","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1196\/annals.1294.020","article-title":"Molecular pathology of the MEN1 gene","volume":"1014","author":"Agarwal","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib152","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1590-8658(02)80212-2","article-title":"Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances","volume":"34","author":"Corleto","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib153","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1210\/jc.85.1.116","article-title":"Genotype\/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas","volume":"85","author":"Goebel","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01654938","article-title":"MEN I pancreas: a histological and immunohistochemical study","volume":"8","author":"Thompson","year":"1984","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib155","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib156","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic)","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib157","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jcem-73-2-281","article-title":"Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds","volume":"73","author":"Skogseid","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib158","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jjco\/hyl052","article-title":"Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment","volume":"36","author":"Shuin","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib159","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib160","first-page":"19","article-title":"Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma","volume":"29","author":"Cappelli","year":"2004","journal-title":"Minerva Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib161","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management","volume":"57","author":"Schwartz","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib162","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2007.01.003","article-title":"Imaging of neuroendocrine tumours (CT\/MR\/US)","volume":"21","author":"Rockall","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.beem.2004.11.013","article-title":"Imaging and localization of islet-cell tumours of the pancreas on CT and MRI","volume":"19","author":"Noone","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib164","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.beem.2004.10.002","article-title":"Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours","volume":"19","author":"Jackson","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib165","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1200\/JCO.2007.14.3065","article-title":"New technologies for human cancer imaging","volume":"26","author":"Frangioni","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib166","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib167","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2006.12.003","article-title":"Nuclear imaging of neuroendocrine tumours","volume":"21","author":"Sundin","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib168","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-125-1-199607010-00005","article-title":"Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas","volume":"125","author":"Gibril","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib169","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/gast.1997.v112.pm9024287","article-title":"Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management","volume":"112","author":"Termanini","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib170","series-title":"A century of advances in neuroendocrine tumor biology and treatment","first-page":"328","article-title":"Uses of radiolabeled somatostatin receptor analogues in diagnosis of gastrointestinal neuroendocrine tumors","author":"Berna","year":"2007"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib171","first-page":"539","article-title":"Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas","volume":"40","author":"Gibril","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib172","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc0802045","article-title":"Glucagon-like peptide 1-receptor scans to localize occult insulinomas","volume":"359","author":"Wild","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib173","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beem.2004.11.001","article-title":"Developments in pancreatic endocrine tumor for the detection of endocrine tumours","volume":"19","author":"Eriksson","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib174","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2007.15.1126","article-title":"Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography","volume":"26","author":"Koopmans","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib175","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography","volume":"90","author":"Orlefors","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib176","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/1078-0432.CCR-09-1759","article-title":"18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors","volume":"16","author":"Binderup","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib177","first-page":"4087","article-title":"Gallium-68 pancreatic endocrine tumor: a new frontier in receptor cancer imaging","volume":"27","author":"Al-Nahhas","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib178","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide pancreatic endocrine tumor in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib179","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1572-0241.2000.02480.x","article-title":"Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas","volume":"95","author":"Anderson","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000325433","article-title":"Islet cell tumor of the pancreas: increasing diagnosis after instituting ultrasonography-guided fine needle aspiration","volume":"52","author":"Caudill","year":"2008","journal-title":"Acta Cytol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib181","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib182","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000140638.55375.1E","article-title":"Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations","volume":"15","author":"Wiesli","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib183","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.gassur.2005.08.012","article-title":"Laparoscopic strategies for resection of insulinomas","volume":"10","author":"Fernandez-Cruz","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib184","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198011203032101","article-title":"Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma","volume":"303","author":"Moertel","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM199202203260804","article-title":"Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma","volume":"326","author":"Moertel","year":"1992","journal-title":"N Engl Med"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib186","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/1097-0142(19900501)65:9<1883::AID-CNCR2820650902>3.0.CO;2-3","article-title":"Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors","volume":"65","author":"Eriksson","year":"1990","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib187","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejca.2003.09.035","article-title":"The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?","volume":"40","author":"Delaunoit","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib188","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1200\/JCO.2004.04.024","article-title":"Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas","volume":"22","author":"Kouvaraki","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2010.10.014_bib189","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000080747","article-title":"Chemotherapy for gastro-enteropancreatic endocrine tumours","volume":"80","author":"O'Toole","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib191","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","article-title":"Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin","volume":"81","author":"Mitry","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib192","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V","article-title":"Treatment with cisplatin and etoposide in patients with neuroendocrine tumors","volume":"92","author":"Fjallskog","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib193","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1158\/1078-0432.CCR-06-2053","article-title":"Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors","volume":"13","author":"Ekeblad","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib194","article-title":"First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas","author":"Strosberg","year":"2010","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib195","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/1078-0432.CCR-08-1476","article-title":"O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors","volume":"15","author":"Kulke","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib196","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","article-title":"Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors","volume":"83","author":"Eriksson","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib197","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","article-title":"Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors","volume":"13","author":"Roche","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib198","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.21389","article-title":"Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival","volume":"104","author":"Gupta","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib199","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","article-title":"Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients","volume":"31","author":"Kennedy","year":"2008","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 2","key":"10.1053\/j.seminoncol.2010.10.014_bib200","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1023\/A:1027352531144","article-title":"Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook","volume":"10","author":"Eriksson","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib201","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/annonc\/mdj113","article-title":"Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma","volume":"17","author":"Panzuto","year":"2006","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"10.1053\/j.seminoncol.2010.10.014_bib202","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1023\/A:1012465801251","article-title":"Chemotherapy and biotherapy in the treatment of neuroendocrine tumours","volume":"12","author":"Oberg","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib203","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0140-6736(86)91435-2","article-title":"Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon","volume":"2","author":"Eriksson","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib204","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/bjc.1992.372","article-title":"Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers","volume":"66","author":"Biesma","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/mdl144","article-title":"Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?","volume":"18","author":"Fazio","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/MO:19:1:35","article-title":"Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs","volume":"19","author":"Fjallskog","year":"2002","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib207","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1542-3565(05)00481-7","article-title":"Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial","volume":"3","author":"Arnold","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib209","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial","volume":"28","author":"Yao","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib210","article-title":"Phase I\/II study of everolimus (RAD001) in combination with temozolomide (TMZ) in patients (pts) with advanced pancreatic neuroendocrine tumors (NET)","author":"Kulke","year":"2010","journal-title":"2010 Gastrointestinal Cancers Symposium"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib211","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","article-title":"Activity of sunitinib in patients with advanced neuroendocrine tumors","volume":"26","author":"Kulke","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.014_bib212","doi-asserted-by":"crossref","unstructured":"Niccoli P, Raoul J, Bang YJ, et al. Uppdated safety and efficacy results of the phase III trial of sunitinib (SU) versus placebo (PBO) for treatment of pancreatic neuroendocrine tumors (NET) [abstract 301s]. ASCO Annual Meeting Proceedings, Chicago, IL; June 4-8, 2010.","DOI":"10.1200\/jco.2010.28.15_suppl.4000"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775410001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775410001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T02:34:38Z","timestamp":1712025278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775410001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":212,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0093775410001843"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2010.10.014","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}